Information Bank Details
Carfilzomib
- Location
- Stored in secure location subject to Ontario Health Internal Data Access Request process.
- Personal Information Maintained
-
Patient ID number, Patient name, Patient province, Date of birth, Current physician name, Dosage data
- Disclosure
-
Not available
- Uses
-
To enroll patients into the New Drug Funding Program and process reimbursement claims.
- Users
-
New Drug Funding Program
- Individuals in the Bank
-
Chemotherapy patients who were receiving the drug Carfilzomib funded by Amgen’s Victory Program.
- Retention and Disposal
- 50 years from the last date of access in accordance with Records Series 900. Data is destroyed following the Media and Data Destruction, Sanitization and Disposal Standard.
Last Updated: June 23, 2025